Genelux
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 26,732 $12.94 $345,912
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 5,803 $14.18 $82,263
Sale
TYREE JAMES L director
 Common Stock 5,653 $12.92 $73,008
Sale
TYREE JAMES L director
 Common Stock 3,347 $13.73 $45,964
Sale
THOMAS JOHN director
 Common Stock 7,073 $13.23 $93,547
Sale
THOMAS JOHN director
 Common Stock 1,927 $13.93 $26,839
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 36,800 $11.85 $436,006
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 18,665 $10.26 $191,559
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 14,594 $11.26 $164,255
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 3,541 $13.04 $46,171
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 5,704 $19.4 $110,640
Option
YU YONG officer: VP, Clinical Trial Ope..
 Stock Option (right to buy) 5,200 $6 $31,200
Option
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 5,200 $6 $31,200
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 5,200 $19.11 $99,351
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 49,987 $19.97 $998,390
Sale
THOMAS JOHN director
 Common Stock 2,452 $20.5 $50,268
Sale
THOMAS JOHN director
 Common Stock 881 $21.3 $18,769
Option
YU YONG officer: VP, Clinical Trial Ope..
 Stock Option (right to buy) 5,200 $6 $31,200
Option
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 5,200 $6 $31,200
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 4,800 $21.94 $105,298
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 400 $22.91 $9,162
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 13,266 $24.89 $330,138
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 985 $25.47 $25,090
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 75,690 $25.49 $1,929,262
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 2,289 $24.12 $55,211
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 11,257 $24.47 $275,459
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 7,465 $22.47 $167,739
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 12,740 $24.03 $306,142
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 9,600 $24.51 $235,296
Option
YU YONG officer: VP, Clinical Trial Ope..
 Stock Option (right to buy) 5,200 $6 $31,200
Option
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 5,200 $6 $31,200
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 1,883 $22.54 $42,443
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 1,114 $23.52 $26,196
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 2,203 $24.46 $53,890
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 3,947 $24.82 $97,965
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 5,511 $25.75 $141,908
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 1,900 $26.6 $50,540
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 1,100 $27.81 $30,591
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 4,421 $26.88 $118,854
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 4,621 $27.76 $128,270
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 2,871 $27.89 $80,064
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 4,678 $28.82 $134,815
Option
YU YONG officer: VP, Clinical Trial Ope..
 Stock Option (right to buy) 6,000 $6 $36,000
Option
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 6,000 $6 $36,000
Sale
YU YONG officer: VP, Clinical Trial Ope..
 Common Stock 6,000 $27.96 $167,784
Option
RYDER SEAN officer: General Counsel
 Stock Option (right to buy) 10,000 $6 $60,000
Option
RYDER SEAN officer: General Counsel
 Common Stock 10,000 $6 $60,000
Sale
RYDER SEAN officer: General Counsel
 Common Stock 10,000 $30 $300,000
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 23,920 $26.21 $626,967
Sale
SZALAY ALADAR 10 percent owner
 Common Stock 8,247 $27.16 $223,980

Showing 50 to 100 of 131 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: